Alpha Biopharma (jiangsu) Co., Ltd.

This study is for people with advanced non-small cell lung cancer that has spread to the brain or spinal cord. It tests a drug called zorifertinib as the first treatment, comparing it to other standard therapies. The goal is to see if zorifertinib helps people live longer and con…